质母细胞瘤:病理学,分子机制和生物标志物的最新情况
Zhong Lan1, Xin Li1, Xiaoqin Zhang1
1Department of Pathology, School of Medicine, South China University of Technology, Guangzhou 510006, China.
International journal of molecular sciences
|March 13, 2024
概括
多型质母细胞瘤 (GBM),一种致命的脑癌,显示出显著的异质性. 了解其分子基础是开发向治疗和改善患者治疗结果的关键.
科学领域:
- 神经瘤学神经瘤学
- 分子病理学分子病理学
- 基因组学就是基因组学.
背景情况:
- 多形质母细胞瘤 (GBM) 是成年人中最常见和最具攻击性的原发性脑瘤.
- 尽管最近取得了进展,但GBM患者的预后仍然很差,因为其具有侵略性和显著的异质性.
- 了解GBM的分子和细胞多样性对于准确的诊断和向治疗至关重要.
研究的目的:
- 在过去十年中,系统地审查了解GBM分子病原体,机制和生物标志物的关键进展.
- 讨论遗传学,表观遗传学,转录组学和与GBM相关的信号通路的进展.
- 探索分子生物标志物的潜在临床作用和未来的治疗策略.
主要方法:
- 系统性文献审查,重点关注GBM分子病原和生物标志物.
- 分析遗传学,表观遗传学,转录组学和信号通路方面的进展.
- 对潜在的临床生物标志物和治疗点的审查.
主要成果:
- 在了解GBM的分子异质性方面取得了重大进展.
- 已经确定了关键的遗传,表观遗传,转录和信号通路变化.
- 几种分子生物标志物显示出在GBM诊断和治疗中临床应用的潜力.
结论:
- 对GBM分子异质性的持续研究对于改善患者的治疗结果至关重要.
- 识别和验证分子生物标志物可以促进针对GBM的向治疗.
- 未来的方向包括发现新的生物标志物和治疗点,以对抗GBM的攻击性.
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...